Table 2 Pharmacokinetic data in serum for all analytes and individuals.

From: Preliminary pharmacokinetic and psychophysical investigations after controlled oral and inhalative consumption of hexahydrocannabinol (HHC)

 

(9R)–HHC

(9S)–HHC

11–OH–HHC

(9R)–HHC–COOH

O1

cmax, ng/mL

12.0

4.39

9.49

37.1

tmax, h

2

2

2.5

2.5

ke

0.41

0.49

0.35

0.0072

t1/2, h

1.70

1.42

1.97

96.1

O2

cmax, ng/mL

7.07

2.47

5.84

10.7

tmax, h

1.25

1.25

2.25

8

ke

t1/2, h

O3

cmax, ng/mL

2.75

1.07

3.66

13.4

tmax, h

1.75

1.75

3

2.75

ke

0.25

0.36

0.24

0.011

t1/2, h

2.78

1.94

2.87

61.8

I1

cmax, ng/mL

15.8

5.93

0.93

1.66

tmax, h

0.05

0.05

0.58

0.25

ke

0.46

0.59

0.27

0.010

t1/2, h

1.52

1.18

2.58

66.2

I2

cmax, ng/mL

179

61.3

3.88

13.6

tmax, h

0.10

0.05

1

0.45

ke

0.35

0.36

0.27

0.0086

t1/2, h

1.97

1.95

2.56

81.0

I3

cmax, ng/mL

142

48.2

4.76

10.5

tmax, h

0.033

0.033

0.10

0.15

ke

0.33

0.37

0.26

0.020

t1/2, h

2.11

1.87

2.64

35.4